High-dose antithrombin therapy for sepsis

Journal of Trauma - Injury, Infection and Critical Care

Volumn 49, Issue 5, 2000, Pages 979-980

  Iba, Toshiaki ^a   Kidokoro, Akio ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN INHIBITOR;

CLINICAL RESEARCH; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; DRUG RESEARCH; HUMAN; INTENSIVE CARE; NOTE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0033664960     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200011000-00034     Document Type: Note

References (9)

1. Septic shock, multiple organ failure and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C and protein S deficiencies
2. The role of the endothelium in changes in procoagulant activity in sepsis
3. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation
4. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation
5. Antithrombin III in patients with severe sepsis: A randomized placebo-controlled double blind multicenter trial
6. Antithrombin III in patients with severe sepsis
7. Antithrombin III (AT III) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomized, multicenter study
8. Antithrombin III supplementation in severe sepsis: Beneficial effects on organ dysfunction
9. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis